Pfizer Inc. recalls Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. L
Recalled October 12, 2022 · FDA recall D-0003-2023 · Pfizer
Hazard
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial. · FDA Class II
Units
103,150 10 mL vials
Sold at
Distributed in the United States and Puerto Rico.
Description
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
Product
Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →